Eurofins Viracor debuts test to measure EBV-specific T-cell immune response

LabPulse.com staff writers
Oct 3, 2022
Test Tubes

Eurofins Viracor, a subsidiary of Eurofins Scientific, on Monday announced the debut of its Epstein-Barr Virus (EBV) inSight test to evaluate T-cell mediated immunity to the Epstein-Barr virus.

Specifically, the test measures CD4 and CD8 Epstein-Barr virus-specific T cell immune response. 

inSight targets EBV cell lysate, BZLF1 (lytic phase), and EBNA3 (latent phase) antigens, Eurofins said, adding that the test reports Interferon-γ (IFN-gamma) and polyfunctional CD4 and CD8 T cells, whose presence has been found to be an indicator of highly functional T cell response.

Latest in Immunoassays
Mycobacterium Tuberculosis Bacteria Niaid Social
Researchers tweak TB treatment assay to support global use
April 10, 2024
Fda Sign Dc Social
BioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panel
March 27, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Cardiac Heart Eeg Social
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
December 6, 2023
Related Stories
Coronavirus Covid Blue Social
Molecular Diagnostics
Immune-response test in study detects COVID-19 with near-perfect accuracy
Viral Like Particles Vaccine
Immunoassays
Bio-Techne, Progen introduce new series of viral titer assays
2022 05 26 14 35 1895 Monkeypox Virus 400
PCR
Eurofins develops monkeypox PCR assay
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Immunoassays
Researchers tweak TB treatment assay to support global use
By Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
Mycobacterium Tuberculosis Bacteria Niaid Social
BioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panel
By LabPulse.com staff writers
BioMérieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.
March 27, 2024
Fda Sign Dc Social
CAP releases updated guideline for validation of IHC assays
By LabPulse.com staff writers
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical assays to provide increased accuracy and consistency in laboratory practices.
February 26, 2024
Modern Lab Equipment Social
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
By Matt Limb
A high-sensitivity blood test can improve diagnosis for 1 in 5 patients who have a heart muscle injury, according to a U.K. hospital study.
December 6, 2023
Cardiac Heart Eeg Social
Danaher cuts cost of rapid TB test after years of pressure from activists
By Nick Paul Taylor
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Bacteria Mycobacterium Tuberculosis Social
Day Zero Diagnostics awarded SBIR grant to develop fecal transplant safety assay
By Matt Limb
Boston-based Day Zero Diagnostics is receiving research funding to support the development of a pharmacovigilance assay to enhance the safety and efficacy of fecal microbiota transplants (FMT) in clinical trials.
September 1, 2023
Research Money Social
Proliferation of infectious disease tests leading to misuse and misinterpretation: Report
By Nick Paul Taylor
The disconnect between changes in demand and capabilities can result in lab directors being asked to oversee testing that is outside of their areas of expertise. Additionally, there are more and more testing options.
July 28, 2023
Lab Test Antibody Social
Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests
By Matt Limb
Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.
July 26, 2023
Bacteria Mycobacterium Tuberculosis Social
Siemens Healthineers adds compact testing system to its IVD portfolio
By LabPulse.com staff writers
The Atellica CI analyzer has a 1.9 square meter footprint, making it ideal for smaller laboratories, but uses the same reagents, consumables, and Atellica Laboratory Evaluation Suite software as the company's Atellica Solution.
July 20, 2023
Test Tube Liquid Sample Social
HPV point-of-care test in development combines isothermal amplification, lateral flow detection
By LabPulse.com staff writers
A testing platform that combines the two technologies often used separately in diagnostic tests could simplify the equipment and procedures needed for HPV testing.
June 23, 2023
Hpv Infection Social
Qiagen describes systematic review for IGRA TB test, blood collection tubes
By Leo O'Connor
The study including 4,050 subjects highlights the value of the TB2 tube and the detection of CD8 T-cell responses for immunocompromised patients, a key risk group for tuberculosis disease, the firm said.
June 15, 2023
Bacteria Mycobacterium Tuberculosis Social
Amid overdose epidemic, NIH and FDA seeking to reduce barriers to rapid drug-detection tools
By LabPulse.com staff writers
The rapid detection tools often remain inaccessible because of gaps in research and other barriers, including state or legal prohibitions.
June 12, 2023
Alcohol Drugs Pills Social
Page 1 of 61
Next Page